Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic dysfuncti...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018-05-01
|
| Serie: | Frontiers in Aging Neuroscience |
| Soggetti: | |
| Accesso online: | http://journal.frontiersin.org/article/10.3389/fnagi.2018.00127/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|